Starbucks is ending GLP-1 coverage for weight loss as employer costs climb
In October, Starbucks will stop covering GLP-1 drugs prescribed for weight loss for benefits-eligible employees.The move comes as GLP-1 drugs consume a growing share of employers' healthcare spending.While some employers retreat from coverage, Bank of America is spending heavily to keep the benefit.Starbucks is pulling back coverage for weight-loss drugs, a reversal that comes as employers' spending on popular GLP-1 medicines soars.Starting in October, the Seattle-based coffee chain's health plans will no longer cover GLP-1 medications prescribed for weight loss for benefits-eligible employees, though the drugs may still be covered for other conditions. Starbucks offers health benefits to full- and part-time employees who work at least 20 hours a week.A spokesperson for Starbucks confirmed the decision, which hasn't previously been reported, and declined to comment further.Starbucks' move reflects a broader recalibration of a benefit that has rapidly reshaped corporate health plans.
Reported by 1 outlet — Business Insider. See all sources ↓
In October, Starbucks will stop covering GLP-1 drugs prescribed for weight loss for benefits-eligible employees.The move comes as GLP-1 drugs consume a growing share of employers' healthcare spending.While some employers retreat from coverage, Bank of America is spending heavily to keep the benefit.Starbucks is pulling back coverage for weight-loss drugs, a reversal that comes as employers' spending on popular GLP-1 medicines soars.Starting in October, the Seattle-based coffee chain's health plans will no longer cover GLP-1 medications prescribed for weight loss for benefits-eligible employees, though the drugs may still be covered for other conditions. Starbucks offers health benefits to full- and part-time employees who work at least 20 hours a week.A spokesperson for Starbucks confirmed the decision, which hasn't previously been reported, and declined to comment further.Starbucks' move reflects a broader recalibration of a benefit that has rapidly reshaped corporate health plans. Originally developed for diabetes, GLP-1 drugs have become highly sought-after treatments for obesity, which is associated with a range of chronic health conditions. Soaring costs, however, are prompting some employers to limit eligibility.GLP-1 drugs accounted for 11.4% of corporate employers' total annual claims last year, up from 6.9% in 2023, according to a 2026 survey by the International Foundation of Employee Benefit Plans, a nonprofit.
Read the full report at Business Insider ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
- What's the story?
- In October, Starbucks will stop covering GLP-1 drugs prescribed for weight loss for benefits-eligible employees.The move comes as GLP-1 drugs consume a growing share of employers' healthcare spending.While some employers retreat from coverage, Bank of America is spending heavily to keep the benefit.Starbucks is pulling back coverage for weight-loss drugs, a reversal that comes as employers' spending on popular GLP-1 medicines soars.Starting in October, the Seattle-based coffee chain's health plans will no longer cover GLP-1 medications prescribed for weight loss for benefits-eligible employees, though the drugs may still be covered for other conditions. Starbucks offers health benefits to full- and part-time employees who work at least 20 hours a week.A spokesperson for Starbucks confirmed the decision, which hasn't previously been reported, and declined to comment further.Starbucks' move reflects a broader recalibration of a benefit that has rapidly reshaped corporate health plans.
- How widely is it covered?
- 1 outlet, average source rating 6.0/10.
- When was it last updated?
- 5m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Starbucks is ending GLP-1 coverage for weight loss as employer costs climb
Sources1TypeCoverageBusiness Insider